467 related articles for article (PubMed ID: 32792454)
21. Efficacy of biofeedback, repetitive transcranial magnetic stimulation and pelvic floor muscle training for female neurogenic bladder dysfunction after spinal cord injury: a study protocol for a randomised controlled trial.
Xu L; Fu C; Zhang Q; Xiong F; Peng L; Liang Z; Chen L; He C; Wei Q
BMJ Open; 2020 Aug; 10(8):e034582. PubMed ID: 32759239
[TBL] [Abstract][Full Text] [Related]
22. Change in urodynamic pattern and incidence of urinary tract infection in patients with traumatic spinal cord injury practicing clean self-intermittent catheterization.
Neyaz O; Srikumar V; Equebal A; Biswas A
J Spinal Cord Med; 2020 May; 43(3):347-352. PubMed ID: 30277852
[No Abstract] [Full Text] [Related]
23. Conditional neuromodulation of neurogenic detrusor overactivity using transrectal stimulation in patients with spinal cord injury: A proof of principle study.
Knight SL; Edirisinghe N; Leaker B; Susser J; Craggs MD
Neurourol Urodyn; 2018 Jan; 37(1):385-393. PubMed ID: 28666061
[TBL] [Abstract][Full Text] [Related]
24. Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact.
Nitti V; Haag-Molkenteller C; Kennelly M; Chancellor M; Jenkins B; Schurch B
Medicine (Baltimore); 2023 Jul; 102(S1):e32377. PubMed ID: 37499088
[TBL] [Abstract][Full Text] [Related]
25. Optimizing clinical trial design using prospective cohort study data: a case study in neuro-urology.
Anderson CE; Birkhäuser V; Stalder SA; Bachmann LM; Curt A; Jordan X; Leitner L; Liechti MD; Mehnert U; Möhr S; Pannek J; Schubert M; van der Lely S; Kessler TM; Brinkhof MWG
Spinal Cord; 2021 Sep; 59(9):1003-1012. PubMed ID: 33235299
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness and safety of oral medications, onabotulinumtoxinA (three doses) and transcutaneous tibial nerve stimulation as non or minimally invasive treatment for the management of neurogenic detrusor overactivity in adults: a systematic review and network meta-analysis.
Chen Y; Peng L; Zhang C; Chen J; Chen J; Shen H; Luo D
Int J Surg; 2023 May; 109(5):1430-1438. PubMed ID: 36974676
[TBL] [Abstract][Full Text] [Related]
29. Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial.
Yeh SD; Khasanah N; Gustafson KJ; Sun C; Tsai ML; Lin BS; Wu CW; Peng CW
Ann Phys Rehabil Med; 2024 Mar; 67(2):101799. PubMed ID: 38128350
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.
Ferreira A; Nascimento D; Cruz CD
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834694
[TBL] [Abstract][Full Text] [Related]
31. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L; Li Y
Int Urol Nephrol; 2015 Mar; 47(3):451-5. PubMed ID: 25609546
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial.
Teixeira Alve A; Azevedo Garcia P; Henriques Jácomo R; Batista de Sousa J; Borges Gullo Ramos Pereira L; Barbaresco Gomide Mateus L; Gomes de Oliveira Karnikoskwi M
Maturitas; 2020 May; 135():40-46. PubMed ID: 32252963
[TBL] [Abstract][Full Text] [Related]
34. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
35. The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-up.
Farrelly E; Lindbo L; Seiger Å
Scand J Urol; 2021 Oct; 55(5):412-418. PubMed ID: 34279177
[TBL] [Abstract][Full Text] [Related]
36. Management of neurogenic detrusor overactivity.
Clark CB; Ragam R; Das AK; Shenot PJ
Can J Urol; 2021 Aug; 28(S2):33-37. PubMed ID: 34453427
[TBL] [Abstract][Full Text] [Related]
37. [Uroflowmetry: A follow-up tool for neurogenic bladder patients treated by transcutaneous tibial posterior stimulation?].
Viallard L; Voiry C; Maze S; Fontaine S; Kerdraon J; Bonan I; Peyronnet B
Prog Urol; 2023 Aug; 33(8-9):421-426. PubMed ID: 36922295
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials.
Bapir R; Bhatti KH; Eliwa A; García-Perdomo HA; Gherabi N; Hennessey D; Magri V; Mourmouris P; Ouattara A; Perletti G; Philipraj J; Stamatiou K; Trinchieri A; Buchholz N
Arch Ital Urol Androl; 2022 Dec; 94(4):492-506. PubMed ID: 36576454
[TBL] [Abstract][Full Text] [Related]
39. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
40. Injecting RNA interference lentiviruses targeting the muscarinic 3 receptor gene into the bladder wall inhibits neurogenic detrusor overactivity in rats with spinal cord injury.
Shang Z; Jia C; Yan H; Cui B; Wu J; Wang Q; Gao W; Cui X; Li J; Ou T
Neurourol Urodyn; 2019 Feb; 38(2):615-624. PubMed ID: 30549314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
